Sponsor Pipeline

Samsung Bioepis Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06348199 A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between… Non-small Cell Lung Cancer Stage IV Active, Not Recruiting
Phase 1
NCT07524348 A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid… Advanced Solid Tumors Recruiting
NCT06268613 A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of… Non-small Cell Lung Cancer Stage II Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2)
Get alerts when Samsung Bioepis Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free